Interpreting Serological Tests in Diagnosing Autoimmune Liver Diseases
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should be a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunofluorescent staining of nuclear dots (suggesting anti-sp100 reactivity) and perinuclear rims (suggesting anti-gp210 reactivity) are useful in the diagnosis of PBC in the 5-10% (depending on the assay) of patients with PBC who are AMA negative [37,[51][52][53][54].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“AMA positivity is observed in more than 90% of patients with PBC [51]; immunofluorescence [1/40, or immunoenzymatic reactivity observed during cholestatic serum liver testing, is highly specific to the disease [52].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“Immunofluorescent staining of nuclear dots (suggesting anti-sp100 reactivity) and perinuclear rims (suggesting anti-gp210 reactivity) are useful in the diagnosis of PBC in the 5-10% (depending on the assay) of patients with PBC who are AMA negative [37,[51][52][53][54].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“immunofluorescence [1/40, or immunoenzymatic reactivity observed during cholestatic serum liver testing, is highly specific to the disease [52].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441005 · Cited by 2,705
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Multiplexed particle-based flow cytometric assays
Vignali, D. A. A. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00238-6 · Cited by 913
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
(2015) · Diagnostic Imaging: Gastrointestinal · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 811
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., zum Büschenfelde, K.-H. M., & Lohse, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02166-8 · Cited by 636
Homberg, J.-C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S. H., Poupon, R., Darnis, F., Lévy, V.-G., Grippon, P., et al. (1987) · Hepatology · doi:10.1002/hep.1840070626 · Cited by 576
Lapierre, P., Hajoui, O., Homberg, J.-C., & Alvarez, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70186-1 · Cited by 538
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“Immunological markers: The diagnostic hallmark of PBC is the presence of AMA, which are detected in serum of more than 90% of affected individuals; the specificity of AMA in PBC is greater than 95% [8].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationCarbone, M., Sharp, S. J., Flack, S., Paximadas, D., Spiess, K., Adgey, C., Griffiths, L., Lim, R., Trembling, P., Williamson, K., et al. (2016) · Hepatology · doi:10.1002/hep.28017 · Cited by 354
“Consistent with other recent series,((7,18,19)) approximately 10% of participants had”
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Autoimmune liver serology: Current diagnostic and clinical challenges
Bogdanos, D. P., Invernizzi, P., Mackay, I. R., & Vergani, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3374 · Cited by 213
Self-citation
Metadata
- Authors
- Invernizzi, P., Lleo, A., & Podda, M.
- Affiliations
- University of Milan (IT)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007-05
- Volume
- 27
- Issue
- 2
- Pages
- 161-172
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2057559137
- Semantic Scholar
- 0a58fc9710d003122ddfa2675fd15232d706cbb4
- Cited by
- 107
- References
- 100
- Citations by year
- 2025: 5 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 13 · 2012: 12
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- autoimmune liver disease, serological tests, serum autoantibodies, primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, antinuclear antibodies, diagnostic biomarkers, non-invasive diagnosis, screening test
- MeSH terms
- Animals, Autoantibodies, Autoimmune Diseases, Humans, Liver Cirrhosis, Biliary, Mass Screening, Predictive Value of Tests, Sensitivity and Specificity, Cholangitis, Sclerosing, Biomarkers, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interpreting Serological Tests in Diagnosing Autoimmune Liver Diseases. https://app.cochat.ai/papers/10.1055/s-2007-979469
- The paper
- Invernizzi, P., Lleo, A., & Podda, M. (2007). Interpreting Serological Tests in Diagnosing Autoimmune Liver Diseases. Seminars in Liver Disease. https://doi.org/10.1055/s-2007-979469
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.